TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 1 | -1 | 13 | -8 | 19 | 15 | 7 |
| P | %wins | 100 | 50 | 100 | 50 | 100 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/14/07 14:41 | 5/11/07 | ENZN | Enzon Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Tooman Craig A | NJ | O | EVP Fina | P | 8 | 8.19 | 6 | 1 | 2 | 52 | D | 15 | -6 | 1 | -9 | 1 | -6 | -3 | -2 | 0 | 1 | 3 | -22 | 20 | 15 |
3/7/06 15:27 | 3/7/06 | ENZN | Enzon Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Tooman Craig A | NJ | O | EVP Fina | P | 7 | 6.87 | 2 | 1 | 4 | 26 | 1 | -2 | 22 | 7 | 18 | 15 | |||||||||
8/28/03 15:05 | 8/28/03 | ILXO | Ilex Oncology Inc | DE | Health | BioPrd | Biological Products, (No Diag | Tooman Craig A | TX | O | VP Inves | P | 3 | 16.22 | 0 | 0 | New | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |